| scholarly article | Q13442814 |
| P356 | DOI | 10.1089/THY.1999.9.47 |
| P698 | PubMed publication ID | 10037076 |
| P2093 | author name string | Doumas A | |
| Halkias A | |||
| Kaltsas T | |||
| Krassas GE | |||
| Pontikides N | |||
| P433 | issue | 1 | |
| P921 | main subject | scintigraphy | Q1130465 |
| eye disease | Q3041498 | ||
| P304 | page(s) | 47-52 | |
| P577 | publication date | 1999-01-01 | |
| P1433 | published in | Thyroid | Q15709940 |
| P1476 | title | Somatostatin receptor scintigraphy before and after treatment with somatostatin analogues in patients with thyroid eye disease | |
| P478 | volume | 9 |
| Q73289879 | Imaging Somatostatin Receptor Activity in Patients with Active Thyroid Eye Disease Using Tc-99m Depreotide |
| Q44712930 | Octreotide scintigraphy for the diagnosis of active Graves' ophthalmopathy |
| Q35600019 | Opportunities in somatostatin research: biological, chemical and therapeutic aspects |
| Q79775301 | Slow-release lanreotide in Graves' ophthalmopathy: A double-blind randomized, placebo-controlled clinical trial |
| Q89977691 | Somatostatin Analogs in Clinical Practice: a Review |
| Q35785161 | Somatostatin analogs: a new tool for the management of Graves' ophthalmopathy |
| Q92971116 | Somatostatin receptor imaging by SPECT and PET in patients with chronic inflammatory disorders: a systematic review |
| Q37239293 | The efficacy of somatostatin analogues in the treatment of diabetic retinopathy and thyroid eye disease. |
| Q34220709 | Thyroid associated ophthalmopathy - a review |
| Q37060099 | Update on advanced imaging options for thyroid-associated orbitopathy |
| Q36886970 | What affects functional ovarian reserve, thyroid function or thyroid autoimmunity? |
| Q76384457 | [Endocrine orbit disorders. Pathogenesis, clinical presentation and examination, stage-dependent therapy] |
Search more.